Hong-Ke Liu

Nanjing Normal University

H指数:28

被引数:3,628

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

COX-2 targeting Ru-arene complexes from metal-ligand synergistic enhancement strategy for breast cancer therapy

基于金属-配体协同增强策略靶向COX-2的钌-芳烃配合物用于乳腺癌治疗

Journal of Inorganic Biochemistry

IF3.2

2025-08-220

PRE

Novel tryptophan 2; 3-dioxygenase-targeted ruthenium(II)-indole complex activates immunotherapy in vitro and in vivo

新型色氨酸2;3-双加氧酶靶向的钌(II)-吲哚配合物在体外和体内激活免疫疗法

Chem. Sci.

IF7.4

2025-08-010

Quinoline-based fluorescent probes with large Stokes shift for sequential Cu2+ and S2− ions detection in bioimaging

喹啉基荧光探针，具有大斯托克斯位移，用于生物成像中Cu2+和S2−离子的顺序检测

Talanta

IF6.1

2025-06-270

PRE

Unusual dynamic stimuli-responsive metallamacrocyclic configurational switches

异常的动态刺激响应金属大环构型开关

Chinese Chemical Letters

IF8.9

2025-05-270

PRE

A mitochondria targeting Ir(III) complex triggers ferroptosis and autophagy for cancer therapy: A case of aggregation enhanced PDT strategy for metal complexes

CHINESE CHEMICAL LETTERS

IF8.9

2025-01-010

PRE

NIR photoactivated electron intersystem crossing to evoke calcium-mediated lysosome-dependent cell death and immunotherapy

NIR光活化电子系统间交叉引起钙介导的溶酶体依赖性细胞死亡和免疫治疗

CHEMICAL ENGINEERING JOURNAL

IF13.2

2024-10-011

PRE

Ruthenium(ii)-Arene Complex Triggers Immunogenic Ferroptosis for Reversing Drug Resistance

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2024-09-230

PRE

Mitochondria-targeted ruthenium complexes can be generated in vitro and in living cells to target triple-negative breast cancer cells by autophagy inhibition

JOURNAL OF INORGANIC BIOCHEMISTRY

IF3.2

2024-07-014

PRE

Molecular probes for super-resolution imaging of drug dynamics

ADVANCED DRUG DELIVERY REVIEWS

IF17.6

2024-07-010

PRE

Consolidating Organometallic Complex Ir-CA Empowers Mitochondria-Directed Chemotherapy against Resistant Cancer via Stemness and Metastasis Inhibition

INORGANIC CHEMISTRY

IF4.7

2024-03-072

PRE

Cyclometalated iridium(III) complexes as anti-breast cancer and anti-metastasis agents via STAT3 inhibition

通过STAT3抑制环金属化铱 (III) 配合物作为抗乳腺癌和抗转移剂

JOURNAL OF INORGANIC BIOCHEMISTRY

IF3.2

2024-02-0111

PRE

Evoking Ferroptosis by Synergistic Enhancement of a Cyclopentadienyl Iridium-Betulin Immune Agonist

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

IF16.9

2023-10-2717

PRE

Novel 1,8-Naphthalimide Derivatives As Antitumor Agents and Potent Demethylase Inhibitors

ACS MEDICINAL CHEMISTRY LETTERS

IF4

2023-10-115

PRE

Immunostimulation with chemotherapy of a ruthenium-arene complex via blockading CD47 signal in chronic myelogenous leukemia cells

JOURNAL OF INORGANIC BIOCHEMISTRY

IF3.2

2023-06-014

PRE

Switching the Mode of Cell Death between Apoptosis and Autophagy by Histone Deacetylase 6 Inhibition Levels

组蛋白去乙酰化酶6抑制水平在细胞凋亡和自噬之间切换细胞死亡模式

CHEMMEDCHEM

IF3.4

2023-01-184

PRE

Selectively attacking tumor cells of Ru/Ir-arene complexes based on meclofenamic acid via cyclooxygenase-2 inhibition

DALTON TRANSACTIONS

IF3.3

2023-01-014

PRE

Unlocking the potential of iridium and ruthenium arene complexes as anti-tumor and anti-metastasis chemotherapeutic agents

JOURNAL OF INORGANIC BIOCHEMISTRY

IF3.2

2023-01-0121

PRE

The cyclometalated iridium (III) complex based on 9-Anthracenecarboxylic acid as a lysosomal-targeted anticancer agent

基于9-蒽羧酸的环金属化铱 (III) 配合物作为溶酶体靶向抗癌剂

JOURNAL OF INORGANIC BIOCHEMISTRY

IF3.2

2022-10-015

PRE

Modification of surface electronic structure via Ru-doping: Porous Ru-CoFeP nanocubes to boost the oxygen evolution reaction

JOURNAL OF POWER SOURCES

IF7.9

2022-07-016

PRE

A New Strategy to Fight Metallodrug Resistance: Mitochondria-Relevant Treatment through Mitophagy to Inhibit Metabolic Adaptations of Cancer Cells

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

IF16.9

2022-05-0551

PRE

Hong-Ke Liu

个人简介

教育背景

工作经历

荣誉奖项

研究方向